Organic Letters
Letter
yields bereft of the bromide substituent, presumably due to
either the Michael addition occurring or instant dehalogena-
tion of the ATRA product. In the case of dimethyl
bromomalonate (8c) unprecedented cyclopropanation was
observed, even though such a starting material is common in
ATRA studies. Cyclopropane 10 was isolated in 57% yield. In
this case, the presence of a base (Cs2CO3) might deprotonate
the ATRA product (traces of which were detected)
consequently inducing cyclization. Acrylates with α- or β-
methyl substituents failed to give desired products. This was
also true for halobenzenes and (2-bromoethyl)benzene.
Acrylates (11a−c) posed much more of a challenge, due to
polymerization or other side reactions occurring, mainly
ATRP, which viciously affected the yield. Consequently, an
excess of an acrylate must be used. In the case of methyl (11a)
and n-butyl acrylate (11c) the yield increased 2-fold to 42%
and 31% respectively. Interestingly, polymerization was not an
issue when using acrylamide (11d) that gave product 12d in
60% yield. (See SI for a full listing of the scope study.)
The proposed mechanism is presented in Scheme 4. The
reduction of catalyst 2a (Co(III)) gave supernucleophilic
16 can react with benzyl bromide 3a to also give intermediate
17 (J), which ultimately leads to product 18 or undergo
polymerization as well as other side reactions (K).
We have developed, to the best of our knowledge, the first
example of the selective cobalt-catalyzed ATRA reaction with
more common ATRP processes being suppressed. The
reaction is catalyzed by hydrophobic vitamin B12, a corrin
cobalt complex, giving products in decent yields. Benzyl
bromides and chlorides bearing electron-donating groups
furnished products in higher yields than those with electron-
withdrawing ones. Interestingly, utilization of aliphatic organic
halides led to products bereft of the halogen substituent, while
for dimethyl bromomalonate (8c) cyclopropane 10 formed
instead.
We assume that the reaction proceeds through a radical
mechanism involving dehalogenation of an organic halide by
the catalyst 2, followed by addition to an olefin followed by the
typical radical propagation.
This work displays vitamin B12 catalysis in a new light, in
terms of its relationship with organic halides. By fine-tuning
the reaction conditions, one can embrace the uniqueness of
this catalyst and expand its application beyond known
biochemical processes.
Scheme 4. Plausible Mechanism for the Vitamin B12
Catalyzed ATRA Reaction
ASSOCIATED CONTENT
* Supporting Information
■
S
The Supporting Information is available free of charge on the
1
Experimental procedures, optimization studies, H and
13C NMR spectra for all new compounds (PDF)
AUTHOR INFORMATION
Corresponding Authors
■
ORCID
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
Financial support for this work was provided by the National
Science Centre (grant: SONATA 2013/11/D/T5/02956 and
OPUS no. 2016/21/B/ST5/03169).
Co(I) 2b (A), which upon reacting with benzyl bromide 3a
gave β-methyl substituted acrylates which failed to give the
desired products. This was also true for halobenzenes and (2-
bromoethyl)benzene cobalt complexes 13 (ESI-MS [M]+ 1127
and [M + CN]+ 1153) and 14 (ESI-MS [M + CN + Na]+
1215) (B). Following the homolytic cleavage radicals 15 (C)
and 16 (D) are liberated. This was further confirmed via the
addition of TEMPO, a radical trapping reagent, into the
reaction mixture, which halted the reaction confirming a
radical based reaction. Benzyl radical 15 then reacts with n-
butyl acrylate (11c) to give intermediate 17 (F), which was
also trapped with TEMPO (ESI-MS [M + Na]+ 398). Radical
15 can also undergo homocoupling, giving bibenzyl (E). In our
opinion, the mechanism adheres to a typical radical
propagation pathway (G), in which a second molecule of
benzyl bromide (3a) reacts with radical 17 forming desired
product 18 and benzyl radical 15. Alternatively, acrylate radical
REFERENCES
■
́
(1) (a) o Proinsias, K.; Giedyk, M.; Gryko, D. Chem. Soc. Rev. 2013,
42, 6605−6619. (b) Brown, K. L. Chem. Rev. 2005, 105, 2075−2149.
(2) Giedyk, M.; Goliszewska, K.; Gryko, D. Chem. Soc. Rev. 2015, 44,
3391−3404.
́
(3) (a) Giedyk, M.; Turkowska, J.; Lepak, S.; Marculewicz, M.; o
Proinsias, K.; Gryko, D. Org. Lett. 2017, 19, 2670−2673. (b) Giedyk,
́
M.; Goliszewska, K.; o Proinsias, K.; Gryko, D. Chem. Commun. 2016,
52, 1389−1392. (c) Shimakoshi, H.; Luo, Z.; Inaba, T.; Hisaeda, Y.
Dalton Trans. 2016, 45, 10173−10180. (d) Ociepa, M.; Baka, O.;
Narodowiec, J.; Gryko, D. Adv. Synth. Catal. 2017, 359, 3560−3565.
(e) Komeyama, K.; Ohata, R.; Kiguchi, S.; Osaka, I. Chem. Commun.
2017, 53, 6401−6404.
(4) (a) Scheffold, R.; Abrecht, S.; Orlinski, R.; Ruf, H.-R.; Stamouli,
P.; Tinembart, O.; Walder, L.; Weymuth, C. Pure Appl. Chem. 1987,
59, 363−372. (b) Erdmann, P.; Schafer, J.; Springer, R.; Zeitz, H.-G.;
C
Org. Lett. XXXX, XXX, XXX−XXX